Accenture and Nvidia Top Thursday’s Market Cap Stock Changes According to Investing.com

Accenture, Nvidia lead Thursday’s market cap stock movers By Investing.com

Thursday’s trading session is witnessing notable movements in stocks across the board, particularly in the mega-cap and large-cap categories. Some stocks are experiencing significant gains post-earnings announcements, while others are facing sharp declines due to various factors. Here’s a look at some of the most significant movers in today’s market, from the largest companies by market cap to smaller firms making waves.

Mega-Cap Movers (Market Cap $200B+):

• Accenture Ltd (NYSE:): Accenture Reports First-Quarter Fiscal 2025 Results; +7.48%
• Nvidia Corp (NASDAQ:): +3.01%
• Oracle Corp (NYSE:): +3.15%

Large-Cap Stock Movers (Market Cap $10B-$200B):

• Darden Restaurants (NYSE:): Darden Restaurants Reports Fiscal 2025 Second Quarter Results; Declares Quarterly Dividend; And Updates Fiscal 2025 Financial Outlook; +15.46%
• Lamb Weston Holdings Inc (NYSE:): Lamb Weston reports dip in Q2 earnings, trims outlook; -20.85%
• Micron Tech (MU): Micron Technology (NASDAQ:), Inc. Reports Results for the First Quarter of Fiscal 2025; -16.21%
• Vertex Pharm (NASDAQ:): Vertex reports mixed results in Phase 2 pain study; -11.95%
• Cintas Corp (NASDAQ:): Cintas stock edges higher on Q2 earnings beat, raised full-year outlook; -9.09%
• Summit Therapeutics PLC (NASDAQ:): +8.33%
• MSTU (MSTU): -8.19%
• FBTC NYSE (FBTC): -1.81%

Mid-Cap Stock Movers (Market Cap $2B-$10B):

• Quantum (NASDAQ:) Computing OTC (QUBT): -43.61%
• Rigetti Computing Inc (NASDAQ:): -29.38%
• DPCM Capital (QBTS): -28.91%
• AltC Acquisition (OKLO): +14.91%
• C3 Ai Inc (NYSE:): -11.26%
• BITX (BITX): -4.35%
• MSTZ (MSTZ): +9.32%
• Oaktree Acquisition Corp (NYSE:): -9.7%
• SoundHound AI (NASDAQ:): -9.23%
• Joby Aviation (NYSE:): -7.35%

Small-Cap Stock Movers (Market Cap $300M-$2B):

• Membership Collective Group (SHCO): +58.25%
• Omeros Corp (NASDAQ:): Omeros reports survival benefit with narsoplimab in TA-TMA; +35.39%
• Prothena Corporation PLC (PRTA): Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease; +40.67%
• Centricus Acquisition (ARQQ): -29.73%
• Cango Inc (NYSE:): -27.13%
• Tuscan Holdings Corp (MVST): +28.26%
• UVIX (UVIX): +13.32%
• Flame Acquisition (SOC): +16.22%
• CMI Acquisition LLC (SKYT): -16.62%
• Innodata Isogen (INOD): +15.53%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source link